Low-grade serous tumors: are we making progress?

N Pauly, S Ehmann, E Ricciardi, B Ataseven… - Current oncology …, 2020 - Springer
Abstract Purpose of Review This review provides an overview of the current clinical standard
in low-grade serous ovarian cancer (LGSOC). The available evidence for surgery and …

Skeletal muscle attenuation (sarcopenia) predicts reduced overall survival in patients with advanced epithelial ovarian cancer undergoing primary debulking surgery

B Ataseven, TG Luengo, A du Bois… - Annals of Surgical …, 2018 - Springer
Background Sarcopenia was reported as a prognostic factor in cancer patients. Using
computed tomography (CT), we analyzed the impact of sarcopenia on overall survival (OS) …

[HTML][HTML] Managing difficulties of microsatellite instability testing in endometrial cancer-limitations and advantages of four different PCR-based approaches

J Siemanowski, B Schoemig-Markiefka, T Buhl, A Haak… - Cancers, 2021 - mdpi.com
Simple Summary Due to the approval of immune checkpoint inhibitor therapy for
microsatellite instability-high or mismatch repair-deficient advanced solid tumors, testing of …

Sentinel lymph node mapping with fluorescent and radioactive tracers in vulvar cancer patients

S Prader, A du Bois, P Harter, E Breit… - Archives of Gynecology …, 2020 - Springer
Purpose Application of radioactive tracers for sentinel lymph node biopsy (SLNB) in vulvar
cancer has been established, however, the use of radioisotopes is expensive and requires …

Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience

N Pauly, T Baert, R Schmutzler, A du Bois… - Archives of Gynecology …, 2021 - Springer
Abstract Purpose Current guidelines for Lynch syndrome detection in endometrial cancer
(EC) patients rely either on risk evaluation, based on personal/family history, or detection of …

[HTML][HTML] Prevalence of BRCA1 and BRCA2 Mutations in Patients with Primary Ovarian Cancer–Does the German Checklist for Detecting the Risk of Hereditary Breast …

B Ataseven, D Tripon, K Rhiem, P Harter… - Geburtshilfe und …, 2020 - thieme-connect.com
Hintergrund BRCA1/2-Mutationen sind die Hauptursache für erbliche epitheliale
Ovarialkarzinome (EOC). Das Deutsche Konsortium für Familiären Brust-und Eierstockkrebs …

2022-RA-781-ESGO MLH1 promoter hypermethylation in mismatch repair deficient endometrial cancer. Defining a new subgroup?

N Pauly, P Harter, F Heitz, M Moubarak, A Traut… - 2022 - ijgc.bmj.com
Introduction/Background Nearly 30% of unselected endometrial cancer (EC) are mismatch
repair deficient (MMRd). The majority resulting from epigenetic changes due to MLH1 …

2022-RA-778-ESGO Rare gynecological cancers in a gynecologic cancer center: 11-year experience of KEM

M Moubarak, B Ataseven, F Heitz, J Welz, B Baran… - 2022 - ijgc.bmj.com
Introduction/Background Many gynecologic cancers fulfill the criteria of a rare tumor with an
annual incidence of< 6 per 100,000 women. As these tumor entities are difficult to treat …

2022-RA-1533-ESGO Role of fertility sparing surgery in patients with borderline ovarian tumors

T Westermann, F Heitz, B Ataseven, N Pauly… - 2022 - ijgc.bmj.com
Introduction/Background Borderline ovarian tumors (BOT) are considered rare tumors of the
ovary and often occur in young patients, which is why fertility-sparing surgery (FSS) is of …

21/# 810 A current perspective on endometrial carcinoma (EC) risk classification: results from an European multicentre initiative

A Rohner, M Grube, K Knoll, A Lum… - International …, 2022 - search.proquest.com
Objectives EC management has been plagued by poor interobserver reproducibility of
histomorphologic features for a long time. More recently integration of TCGA-inspired …